News

In recent years, laparoscopic surgery, a minimally invasive procedure aimed at reducing the physical burden on patients, has been increasingly performed. The demand for surgical robots that support more precise procedures has been growing, and they are being utilized across a wide range of medical specialties. It is anticipated that the global market size for surgical robots will continue to expand in response to the increasing worldwide demand.

Following the introduction of hinotori™ in Singapore in October 2024, the first robotic-assisted surgery using hinotori™ was performed in Malaysia, making it the second country outside of Japan to adopt this system. The procedure was performed at Mahkota Medical Centre, the first hospital in Malacca to become accredited by Joint Commission International (JCI) which internationally recognizes them for their best-in-class standards in patient safety and quality of care standards. Additionally, hinotori™ has also been installed at Regency Specialist Hospital, a leading comprehensive care hospital in southeast asia. Both reputable hospitals are a part of HMI Medical, a regional healthcare committed to advancing healthcare and changing lives for communities across Southeast Asia. 

Since the end of October 2024, surgeries using hinotori™ have been continuously performed in Singapore, and our business is making steady progress in the global market.

By providing hinotori™, which helps reduce the physical burden on patients, Sysmex aims to contribute to achieving a safer and more efficient surgical environment to make each individual’s healthcare journey better.

 

* hinotori™ is a registered trademark of Medicaroid Corporation. Sysmex serves as the global distributor for Medicaroid's hinotori™, handling sales both domestically and internationally.